Rex D. Geveden - 12 Feb 2026 Form 4 Insider Report for BWX Technologies, Inc. (BWXT)

Role
President and CEO, Director
Signature
/s/ Rex D. Geveden, by Theresa B. Taylor, attorney-in-fact
Issuer symbol
BWXT
Transactions as of
12 Feb 2026
Net transactions value
-$2,032,560
Form type
4
Filing time
13 Feb 2026, 16:11:07 UTC
Previous filing
13 Nov 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Geveden Rex D President and CEO, Director 800 MAIN STREET, 4TH FLOOR, LYNCHBURG /s/ Rex D. Geveden, by Theresa B. Taylor, attorney-in-fact 13 Feb 2026 0001408482

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BWXT Common Stock Sale $90,668 -454 -0.24% $199.71 187,140 12 Feb 2026 Direct F1, F2
transaction BWXT Common Stock Sale $239,388 -1,190 -0.64% $201.17 185,950 12 Feb 2026 Direct F1, F3
transaction BWXT Common Stock Sale $356,355 -1,762 -0.95% $202.24 184,188 12 Feb 2026 Direct F1, F4
transaction BWXT Common Stock Sale $445,474 -2,192 -1.2% $203.23 181,996 12 Feb 2026 Direct F1, F5
transaction BWXT Common Stock Sale $388,514 -1,904 -1% $204.05 180,092 12 Feb 2026 Direct F1, F6
transaction BWXT Common Stock Sale $512,161 -2,498 -1.4% $205.03 177,594 12 Feb 2026 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/11/2025.
F2 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $199.5500 to $200.2300 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F3 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $200.6050 to $201.6000 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $201.7700 to $202.6700 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $202.8000 to $203.6700 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $203.8550 to $204.7600 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7 The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $204.9250 to $205.2850 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.